Loading…

Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice. e70618

Background With a wide range of applications, titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities. Recently, in the field of nanomedicine, intravenous injection of TiO2 nanoparticulate carriers directly into the bloodstream has raised public concerns on their t...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2013-08, Vol.8 (8)
Main Authors: Xu, Jiaying, Shi, Hongbo, Ruth, Magaye, Yu, Hongsheng, Lazar, Lissy, Zou, Baobo, Yang, Cui, Wu, Aiguo, Zhao, Jinshun
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 8
container_start_page
container_title PloS one
container_volume 8
creator Xu, Jiaying
Shi, Hongbo
Ruth, Magaye
Yu, Hongsheng
Lazar, Lissy
Zou, Baobo
Yang, Cui
Wu, Aiguo
Zhao, Jinshun
description Background With a wide range of applications, titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities. Recently, in the field of nanomedicine, intravenous injection of TiO2 nanoparticulate carriers directly into the bloodstream has raised public concerns on their toxicity to humans. Methods In this study, mice were injected intravenously with a single dose of TiO2 NPs at varying dose levels (0, 140, 300, 645, or 1387 mg/kg). Animal mortality, blood biochemistry, hematology, genotoxicity and histopathology were investigated 14 days after treatment. Results Death of mice in the highest dose (1387 mg/kg) group was observed at day two after TiO2 NPs injection. At day 7, acute toxicity symptoms, such as decreased physical activity and decreased intake of food and water, were observed in the highest dose group. Hematological analysis and the micronucleus test showed no significant acute hematological or genetic toxicity except an increase in the white blood cell (WBC) count among mice 645 mg/kg dose group. However, the spleen of the mice showed significantly higher tissue weight/body weight (BW) coefficients, and lower liver and kidney coefficients in the TiO2 NPs treated mice compared to control. The biochemical parameters and histological tissue sections indicated that TiO2 NPs treatment could induce different degrees of damage in the brain, lung, spleen, liver and kidneys. However, no pathological effects were observed in the heart in TiO2 NPs treated mice. Conclusions Intravenous injection of TiO2 NPs at high doses in mice could cause acute toxicity effects in the brain, lung, spleen, liver, and kidney. No significant hematological or genetic toxicity was observed.
doi_str_mv 10.1371/journal.pone.0070618
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1512335568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1512335568</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_15123355683</originalsourceid><addsrcrecordid>eNqVjbtuAjEQAK1IkSCPP6DYkoaLfdaZo0QJCApSXZcCWb5FWuRbX_yIwt8HIX4g1TQzGiFmSlZKL9XbOZTI1ldjYKykXEqj2gcxVStdL0wt9UQ8pXSWstGtMVPxtXYlI3ThlxzlC4QT7DlH-4McSvIXWPcDMaWMEXvoKFumMsAHXYMe4dNyGG3M5DwmIIYDOawAb9sX8XiyPuHrnc9ivt1077vFGMN3wZSPAyWH3lvG6-yoGlVr3TSm1f9Q_wATPU3X</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1512335568</pqid></control><display><type>article</type><title>Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice. e70618</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Xu, Jiaying ; Shi, Hongbo ; Ruth, Magaye ; Yu, Hongsheng ; Lazar, Lissy ; Zou, Baobo ; Yang, Cui ; Wu, Aiguo ; Zhao, Jinshun</creator><creatorcontrib>Xu, Jiaying ; Shi, Hongbo ; Ruth, Magaye ; Yu, Hongsheng ; Lazar, Lissy ; Zou, Baobo ; Yang, Cui ; Wu, Aiguo ; Zhao, Jinshun</creatorcontrib><description>Background With a wide range of applications, titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities. Recently, in the field of nanomedicine, intravenous injection of TiO2 nanoparticulate carriers directly into the bloodstream has raised public concerns on their toxicity to humans. Methods In this study, mice were injected intravenously with a single dose of TiO2 NPs at varying dose levels (0, 140, 300, 645, or 1387 mg/kg). Animal mortality, blood biochemistry, hematology, genotoxicity and histopathology were investigated 14 days after treatment. Results Death of mice in the highest dose (1387 mg/kg) group was observed at day two after TiO2 NPs injection. At day 7, acute toxicity symptoms, such as decreased physical activity and decreased intake of food and water, were observed in the highest dose group. Hematological analysis and the micronucleus test showed no significant acute hematological or genetic toxicity except an increase in the white blood cell (WBC) count among mice 645 mg/kg dose group. However, the spleen of the mice showed significantly higher tissue weight/body weight (BW) coefficients, and lower liver and kidney coefficients in the TiO2 NPs treated mice compared to control. The biochemical parameters and histological tissue sections indicated that TiO2 NPs treatment could induce different degrees of damage in the brain, lung, spleen, liver and kidneys. However, no pathological effects were observed in the heart in TiO2 NPs treated mice. Conclusions Intravenous injection of TiO2 NPs at high doses in mice could cause acute toxicity effects in the brain, lung, spleen, liver, and kidney. No significant hematological or genetic toxicity was observed.</description><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0070618</identifier><language>eng</language><ispartof>PloS one, 2013-08, Vol.8 (8)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906,36994</link.rule.ids></links><search><creatorcontrib>Xu, Jiaying</creatorcontrib><creatorcontrib>Shi, Hongbo</creatorcontrib><creatorcontrib>Ruth, Magaye</creatorcontrib><creatorcontrib>Yu, Hongsheng</creatorcontrib><creatorcontrib>Lazar, Lissy</creatorcontrib><creatorcontrib>Zou, Baobo</creatorcontrib><creatorcontrib>Yang, Cui</creatorcontrib><creatorcontrib>Wu, Aiguo</creatorcontrib><creatorcontrib>Zhao, Jinshun</creatorcontrib><title>Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice. e70618</title><title>PloS one</title><description>Background With a wide range of applications, titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities. Recently, in the field of nanomedicine, intravenous injection of TiO2 nanoparticulate carriers directly into the bloodstream has raised public concerns on their toxicity to humans. Methods In this study, mice were injected intravenously with a single dose of TiO2 NPs at varying dose levels (0, 140, 300, 645, or 1387 mg/kg). Animal mortality, blood biochemistry, hematology, genotoxicity and histopathology were investigated 14 days after treatment. Results Death of mice in the highest dose (1387 mg/kg) group was observed at day two after TiO2 NPs injection. At day 7, acute toxicity symptoms, such as decreased physical activity and decreased intake of food and water, were observed in the highest dose group. Hematological analysis and the micronucleus test showed no significant acute hematological or genetic toxicity except an increase in the white blood cell (WBC) count among mice 645 mg/kg dose group. However, the spleen of the mice showed significantly higher tissue weight/body weight (BW) coefficients, and lower liver and kidney coefficients in the TiO2 NPs treated mice compared to control. The biochemical parameters and histological tissue sections indicated that TiO2 NPs treatment could induce different degrees of damage in the brain, lung, spleen, liver and kidneys. However, no pathological effects were observed in the heart in TiO2 NPs treated mice. Conclusions Intravenous injection of TiO2 NPs at high doses in mice could cause acute toxicity effects in the brain, lung, spleen, liver, and kidney. No significant hematological or genetic toxicity was observed.</description><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqVjbtuAjEQAK1IkSCPP6DYkoaLfdaZo0QJCApSXZcCWb5FWuRbX_yIwt8HIX4g1TQzGiFmSlZKL9XbOZTI1ldjYKykXEqj2gcxVStdL0wt9UQ8pXSWstGtMVPxtXYlI3ThlxzlC4QT7DlH-4McSvIXWPcDMaWMEXvoKFumMsAHXYMe4dNyGG3M5DwmIIYDOawAb9sX8XiyPuHrnc9ivt1077vFGMN3wZSPAyWH3lvG6-yoGlVr3TSm1f9Q_wATPU3X</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Xu, Jiaying</creator><creator>Shi, Hongbo</creator><creator>Ruth, Magaye</creator><creator>Yu, Hongsheng</creator><creator>Lazar, Lissy</creator><creator>Zou, Baobo</creator><creator>Yang, Cui</creator><creator>Wu, Aiguo</creator><creator>Zhao, Jinshun</creator><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130801</creationdate><title>Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice. e70618</title><author>Xu, Jiaying ; Shi, Hongbo ; Ruth, Magaye ; Yu, Hongsheng ; Lazar, Lissy ; Zou, Baobo ; Yang, Cui ; Wu, Aiguo ; Zhao, Jinshun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_15123355683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Jiaying</creatorcontrib><creatorcontrib>Shi, Hongbo</creatorcontrib><creatorcontrib>Ruth, Magaye</creatorcontrib><creatorcontrib>Yu, Hongsheng</creatorcontrib><creatorcontrib>Lazar, Lissy</creatorcontrib><creatorcontrib>Zou, Baobo</creatorcontrib><creatorcontrib>Yang, Cui</creatorcontrib><creatorcontrib>Wu, Aiguo</creatorcontrib><creatorcontrib>Zhao, Jinshun</creatorcontrib><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Jiaying</au><au>Shi, Hongbo</au><au>Ruth, Magaye</au><au>Yu, Hongsheng</au><au>Lazar, Lissy</au><au>Zou, Baobo</au><au>Yang, Cui</au><au>Wu, Aiguo</au><au>Zhao, Jinshun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice. e70618</atitle><jtitle>PloS one</jtitle><date>2013-08-01</date><risdate>2013</risdate><volume>8</volume><issue>8</issue><eissn>1932-6203</eissn><abstract>Background With a wide range of applications, titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities. Recently, in the field of nanomedicine, intravenous injection of TiO2 nanoparticulate carriers directly into the bloodstream has raised public concerns on their toxicity to humans. Methods In this study, mice were injected intravenously with a single dose of TiO2 NPs at varying dose levels (0, 140, 300, 645, or 1387 mg/kg). Animal mortality, blood biochemistry, hematology, genotoxicity and histopathology were investigated 14 days after treatment. Results Death of mice in the highest dose (1387 mg/kg) group was observed at day two after TiO2 NPs injection. At day 7, acute toxicity symptoms, such as decreased physical activity and decreased intake of food and water, were observed in the highest dose group. Hematological analysis and the micronucleus test showed no significant acute hematological or genetic toxicity except an increase in the white blood cell (WBC) count among mice 645 mg/kg dose group. However, the spleen of the mice showed significantly higher tissue weight/body weight (BW) coefficients, and lower liver and kidney coefficients in the TiO2 NPs treated mice compared to control. The biochemical parameters and histological tissue sections indicated that TiO2 NPs treatment could induce different degrees of damage in the brain, lung, spleen, liver and kidneys. However, no pathological effects were observed in the heart in TiO2 NPs treated mice. Conclusions Intravenous injection of TiO2 NPs at high doses in mice could cause acute toxicity effects in the brain, lung, spleen, liver, and kidney. No significant hematological or genetic toxicity was observed.</abstract><doi>10.1371/journal.pone.0070618</doi></addata></record>
fulltext fulltext
identifier EISSN: 1932-6203
ispartof PloS one, 2013-08, Vol.8 (8)
issn 1932-6203
language eng
recordid cdi_proquest_miscellaneous_1512335568
source Publicly Available Content Database; PubMed Central
title Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice. e70618
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T16%3A33%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Toxicity%20of%20Intravenously%20Administered%20Titanium%20Dioxide%20Nanoparticles%20in%20Mice.%20e70618&rft.jtitle=PloS%20one&rft.au=Xu,%20Jiaying&rft.date=2013-08-01&rft.volume=8&rft.issue=8&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0070618&rft_dat=%3Cproquest%3E1512335568%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_15123355683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1512335568&rft_id=info:pmid/&rfr_iscdi=true